Likely Pathogenic APOA5 Variant Linked to High Triglycerides in Chinese Family

This case report examined eight members of a Chinese family to understand the effects of an APOA5 variant known as p.R223C. The team compared those carrying the genetic change with family members who did not carry it. They found that individuals with the variant had substantially higher fasting plasma triglyceride levels than the admitted threshold of 1.7 mmol/L. Among the six carriers, five had elevated triglycerides, while the single non-carrier had normal levels. One carrier reached a peak level of 4.96 mmol/L. The genetic change was classified as Likely Pathogenic according to ACMG/AMP guidelines. The report notes that preliminary in silico verification was used. No adverse events or safety concerns were reported because this was a case report without a control group or intervention. Readers should be cautious because rare genetic variants observed in isolated cases are often difficult to establish conclusively. The real effect of this variant requires further investigation via biochemical or cell-based studies. This preliminary finding does not change current medical practice yet.